Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models DOI Open Access

Ki-Chan Kim,

Ga Hee Jeong, Chul Hwan Bang

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13539 - 13539

Published: Dec. 18, 2024

Cannabichromene (CBC) is one of the main cannabinoids found in cannabis plant, and although less well known than tetrahydrocannabinol (THC) cannabidiol (CBD), it gaining attention for its potential therapeutic benefits. To date, CBC’s mechanisms action include anti-inflammatory, analgesic, antidepressant, antimicrobial, neuroprotective, anti-acne effects through TRP channel activation inhibition inflammatory pathways, suggesting that may have treatment skin diseases, such as atopic dermatitis (AD), but exact mechanism remains unclear. Therefore, this study, we investigated CBC on Th2 cytokines along with Janus kinase (JAK)/signal transducer activator transcription (STAT) pathways involved AD pathogenesis. We used a 2,4-Dinitrochlorobenzene (DNCB)-induced BALB/c mouse model to topically administer (0.1 mg/kg or 1 mg/kg). The results showed lesion severity, ear thickness, epithelial thickness dorsal skin, mast cell infiltration were significantly reduced 0.1 CBC-treated group compared DNCB-treated (p < 0.001). In addition, real-time quantitative reverse polymerase chain reaction (qRT-PCR) analysis significant decrease mRNA expression (TSLP, IL-4, IL-13) mediators (IFN-γ, IL-1β, IL-6, IL-17, IL-18, IL-33) 0.05). Western blot also revealed JAK1, JAK2, STAT1, STAT2, STAT3, STAT6 protein These suggest promising candidate demonstrates alleviate symptoms by suppressing immune response.

Language: Английский

Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses DOI

Mengsong Liu,

Mulan Chen,

Junwen Tan

et al.

Archives of Dermatological Research, Journal Year: 2024, Volume and Issue: 316(7)

Published: July 1, 2024

Language: Английский

Citations

1

Impact of inflammatory skin conditions on the biological profile of plasma rich in growth factor DOI
Eduardo Anitua, Roberto Tierno,

Zuriñe Martínez de Lagrán

et al.

Tissue and Cell, Journal Year: 2024, Volume and Issue: 91, P. 102560 - 102560

Published: Sept. 14, 2024

Language: Английский

Citations

1

Changes in Gene Expression Related to Atopic Dermatitis in Mothers and Infants Following VOC Exposure DOI Open Access
Seung Hwan Kim, So Yeon Yu,

Jeong Hyeop Choo

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(23), P. 12827 - 12827

Published: Nov. 28, 2024

Environmental pollutants, particularly volatile organic compounds (VOCs), are associated with various diseases, including atopic dermatitis (AD). However, despite numerous studies on AD, there is a lack of research the impact environmental exposures mothers and infants. This study, therefore, investigated effects maternal exposure to specific VOCs (toluene, xylene, benzene) expression AD-related genes in their RNA levels DNA methylation patterns were analyzed examine correlation between AD. A multi-omics approach integrating gene data was additionally employed gain broader understanding genetic VOC exposure. Network analysis revealed significant changes For example, toluene resulted upregulation AQP10, which linked keratinocyte dysfunction, infants, IL31RA CCL20 notably affected, both play critical roles immune response skin barrier function. In exposed histamine receptor HRH1 identified as key player influencing AD through its role recovery, while infants exhibited consistent network responses downregulation TIGIT, reflecting shared across different xylene isomers. Interestingly, isomers displayed nearly identical patterns, suggesting developmental resistance diverse factors. No benzene-exposed group. These findings suggest that may have related highlighting complexity how factors contribute disease development.

Language: Английский

Citations

0

Atopic dermatitis in children of the first year of life: clinical and pathogenetic aspects, modern views on treatment from the perspective of a dermatologist DOI

V. Yu. Ujukhu,

A.A. Kubylinskiy

Medical alphabet, Journal Year: 2024, Volume and Issue: 24, P. 16 - 22

Published: Dec. 5, 2024

Atopic dermatitis is one of the most common skin diseases in children. Genetic disorders that determine development persistent dysfunction cellular immunity play an important role clinical symptoms atopic dermatitis. In new concept occurrence manifestations (AD), T-regulatory lymphocytes are assigned, form CD4+CD25+ phenotype, which controlled by transcription factor FoxP3. The study mechanism itching, more or less observed all children with blood pressure, showed case island-inflammatory course Th2-dependent itching histamine-conditioned. According to «Outside Inside – outside inside», significant mechanisms causing appearance pressure a genetic predisposition causes formation allergic reactions, changes permeability epidermal barrier, against background transepidermal moisture loss, xerosis phenomena and decrease threshold. Significant abnormalities state microbiota were found AD. species composition intestinal AD differs significantly from healthy skin. Intestinal microbiocenosis largely determines direction morphofunctional processes epidermis, means translocation bacteria regulating humoral response directly Most often, reactions triggered when food proteins enter body. Among other allergens, cow’s milk protein young many cases, 1-year-old AD, goat’s mixtures good alternative milk-based mixtures. At present stage, complex therapeutic measures first year life diet therapy active external therapy, including phased use topical steroids, calcineurin inhibitors, emollients.

Language: Английский

Citations

0

Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models DOI Open Access

Ki-Chan Kim,

Ga Hee Jeong, Chul Hwan Bang

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13539 - 13539

Published: Dec. 18, 2024

Cannabichromene (CBC) is one of the main cannabinoids found in cannabis plant, and although less well known than tetrahydrocannabinol (THC) cannabidiol (CBD), it gaining attention for its potential therapeutic benefits. To date, CBC’s mechanisms action include anti-inflammatory, analgesic, antidepressant, antimicrobial, neuroprotective, anti-acne effects through TRP channel activation inhibition inflammatory pathways, suggesting that may have treatment skin diseases, such as atopic dermatitis (AD), but exact mechanism remains unclear. Therefore, this study, we investigated CBC on Th2 cytokines along with Janus kinase (JAK)/signal transducer activator transcription (STAT) pathways involved AD pathogenesis. We used a 2,4-Dinitrochlorobenzene (DNCB)-induced BALB/c mouse model to topically administer (0.1 mg/kg or 1 mg/kg). The results showed lesion severity, ear thickness, epithelial thickness dorsal skin, mast cell infiltration were significantly reduced 0.1 CBC-treated group compared DNCB-treated (p < 0.001). In addition, real-time quantitative reverse polymerase chain reaction (qRT-PCR) analysis significant decrease mRNA expression (TSLP, IL-4, IL-13) mediators (IFN-γ, IL-1β, IL-6, IL-17, IL-18, IL-33) 0.05). Western blot also revealed JAK1, JAK2, STAT1, STAT2, STAT3, STAT6 protein These suggest promising candidate demonstrates alleviate symptoms by suppressing immune response.

Language: Английский

Citations

0